Related Experiment Videos

Inhibition of protein kinase C protects against paraoxon-mediated neuronal cell death

Feng Tian1, Xuan Wu, Hongan Pan

  • 1Department of Neurology and Program in Neuroscience, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA.

Neurotoxicology
|June 15, 2007
PubMed

Insights

Paraoxon, an acetylcholinesterase inhibitor, causes neuron death. Protein kinase C (PKC) activation is essential for this neurotoxicity, as inhibiting PKC protects neurons from paraoxon-induced apoptosis.

Area of Science:

  • Neuroscience
  • Toxicology
  • Cell Biology

Background:

  • Paraoxon, the active metabolite of parathion, is a known acetylcholinesterase (AChE) inhibitor.
  • Paraoxon induces apoptosis in cultured cerebellar granule cell neurons.
  • The role of Protein Kinase C (PKC) in paraoxon-induced neurotoxicity remains uncharacterized.

Purpose of the Study:

  • To investigate the involvement of Protein Kinase C (PKC) in paraoxon-induced neuronal cell death.
  • To determine if modulating PKC activity affects paraoxon neurotoxicity.

Main Methods:

  • Treatment of cultured cerebellar granule cell neurons with paraoxon.
  • Utilizing a PKC activator, phorbol 12-myristate 13-acetate (TPA), to enhance PKC activity.
  • Employing a PKC inhibitor, Ro-31-8220, to block PKC activity.
  • Assessing neuronal viability and apoptosis markers, including caspase-3 activity and phospho-PKC levels.

Main Results:

  • Paraoxon exposure increased PKC phosphorylation.
  • The PKC activator TPA enhanced paraoxon's neurotoxic effects by 28%.
  • The PKC inhibitor Ro-31-8220 protected over 30% of neurons from paraoxon-induced death and reduced phospho-PKC levels.
  • Ro-31-8220 pretreatment completely inhibited paraoxon-induced caspase-3 activity.

Conclusions:

  • Activation of Protein Kinase C (PKC) is a critical requirement for paraoxon-induced neurotoxicity.
  • Targeting PKC may offer a therapeutic strategy against paraoxon poisoning.